Helsinn announces FDA acceptance of IND application for TAS0953/HM06 in Patients with Advanced Solid Tumors with RET Gene Abnormalities 8 June 2020
Helsinn Group announces FDA approval of a new liquid formulation of AKYNZEO® (fosnetupitant/palonosetron) injection in the United States 2 June 2020
Open Accelerator: the international program for start-ups in Life Science is back with a new Call for Solutions 26 May 2020
DA IBSA OLTRE 700.000 CHF PER COMBATTERE L’EMERGENZA COVID-19 DI QUESTI 245.000 CHF DONATI DAI LAVORATORI IBSA A SOSTEGNO DELLE FAMIGLIE IN DIFFICOLTÀ 13 May 2020
Helsinn and MEI Pharma Announce Updated Clinical Data from the Phase 2 Study Evaluating Pracinostat in Combination with Azacitidine in Patients with High/Very-high Risk Myelodysplastic Syndromes 13 May 2020
IBSA DONA ALL’UFFICIO DEL MEDICO CANTONALE I TEST SIEROLOGICI PER L’INDIVIDUAZIONE DEGLI ANTICORPI AL COVID-19 8 May 2020
Farma Industria Ticino realizza una filiera produttiva locale di etanolo donando 940 litri all’EOC 23 April 2020
Linkedin